Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01269801 · ClinicalTrials.gov registry record · Phase 4
Study of BOTOX and JUVEDERM for Treatment of Moderate to Severe Facial Wrinkles and Folds
A Phase 4 study of Wrinkles, sponsored by AboutSkin Dermatology and DermSurgery, PC.
- Completed
- Registry status
- Phase 4
- Development phase
- 156
- Enrollment target
- 3
- Study locations
NCT01269801: Completed Phase 4 study of Wrinkles, sponsored by AboutSkin Dermatology and DermSurgery, PC.
NCT01269801 is a Phase 4 study of Wrinkles that has completed, run by AboutSkin Dermatology and DermSurgery, PC. The registered enrollment target is 156 participants, above the 34-participant average among 7 other Wrinkles trials with a reported enrollment target (359% higher). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01269801, a Phase 4 study of Wrinkles, has completed, sponsored by AboutSkin Dermatology and DermSurgery, PC.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 156 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to see how well Juvederm Ultra XC or Juvederm Ultra Plus XC, and BOTOX Cosmetic, work compared to each other and when used together for the cosmetic treatment of age-associated wrinkles and folds of the face.
Primary Outcome
Assessments at Visits 3,5,6+7 (weeks 4,8,12,24) include: -Physician Global Aesthetic Improvement Scale (PGAIS). Ratings include no change, improved, much improved, very much improved. Number of subjects with improvement score for the 5 point PGAIS from baseline to Visit 7. -Objective Observer Global Aesthetic Improvement Scale Number of subjects with improvement score for the from baseline to Visit 7. Ratings include no change, some improvement, definite improvement, substantial improvement,
Conditions Studied
Interventions
- DRUG onabotulinumtoxinA
- DRUG JUVÉDERM
Study Locations (3)
Ontario
- Niagara Falls Dermantology and Skin Care Center - Niagara Falls
- University of Toronto - Toronto
Colorado
- About Skin Dermatology - Englewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-02 |
| Phase | Phase 4 |
What the finished NCT01269801 record still lists
NCT01269801 is an interventional study that assigns participants to a tested intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap, above the 34-participant average among 7 other Wrinkles trials with a reported enrollment target (359% higher).
The record links to 1 condition, with Wrinkles appearing as the primary indexed condition, and to 2 interventions - of which onabotulinumtoxinA is the first listed.
NCT01269801 reports a single indexed study location in Ontario, Colorado.
Frequently Asked Questions
What is clinical trial NCT01269801 about?
NCT01269801 is a clinical study titled "Study of BOTOX and JUVEDERM for Treatment of Moderate to Severe Facial Wrinkles and Folds". The purpose of this study is to see how well Juvederm Ultra XC or Juvederm Ultra Plus XC, and BOTOX Cosmetic, work compared to each other and when used together for the cosmetic treatment of age-associated wrinkles and folds of the face.
What is the current status of trial NCT01269801?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 156 participants. The study started on 2011-01. Estimated completion is 2012-02.
What conditions does trial NCT01269801 study?
This clinical trial studies the following conditions: Wrinkles.
What interventions are being tested in trial NCT01269801?
The interventions under investigation include: onabotulinumtoxinA (DRUG), JUVÉDERM (DRUG).
Who is sponsoring clinical trial NCT01269801?
This trial is sponsored by AboutSkin Dermatology and DermSurgery, PC, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01269801 being conducted?
This trial has 3 study locations across Colorado, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wrinkles
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fractional Laser vs. Ultrasound for Periorbital Wrinkles
ACTIVE NOT RECRUITING · Early Phase 1
-
A Pilot Study Testing Onabotulinum Toxin A Versus Incobotulinum Toxin A Injections for Facial Wrinkles
ACTIVE NOT RECRUITING · Early Phase 1
-
Evaluating the Safety and Efficacy of the Pico Laser With a Specialized Lens Array for the Treatment of Wrinkles
COMPLETED · NA
-
The Effect of Topical Almond Oil vs. Topical Retinol on The Appearance of Facial Wrinkles
COMPLETED · NA
-
A Clinical Study to Evaluate Efficacy and Safety of a Cosmetic Product in the Treatment of Facial Lines
COMPLETED · NA
-
Pilot Study of Triphala and Rubia Cordifolia on Gut Microbiome and Skin
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03082755 · 156 participants · Phase 4
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- NCT04047628 · 156 participants · Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- NCT04166877 · 156 participants · Phase 4
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
- NCT04533464 · 156 participants · Phase 2
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia